SOP Guide for Pharma

Sterile Injectable Manufacturing: SOP for Conducting Quality Audits in Injectable Manufacturing – V 2.0

Sterile Injectable Manufacturing: SOP for Conducting Quality Audits in Injectable Manufacturing – V 2.0

Standard Operating Procedure for Conducting Quality Audits in Injectable Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/083/2025
Supersedes SOP/SIM/083/2022
Page No. Page 1 of 15
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To define the procedure for conducting internal quality audits within the sterile injectable manufacturing facility to assess compliance with cGMP, company standards, and regulatory expectations, and to identify areas of improvement.

2. Scope

This SOP applies to all departments and

operations within the sterile injectable manufacturing facility that are subject to internal audits, including production, QA, QC, engineering, and warehouse operations.

3. Responsibilities

  • Lead Auditor: Plans, conducts, and reports audits; ensures objectivity and compliance with audit scope.
  • Audit Team Members: Participate in audit execution and documentation.
  • Auditees: Provide required documentation, access, and clarifications during audits.
  • QA Head: Reviews audit findings and ensures implementation of corrective and preventive actions (CAPA).

4. Accountability

The Head – Quality Assurance is accountable for ensuring that internal audits are conducted periodically and that all observations are addressed through timely CAPA implementation.

5. Procedure

5.1 Audit Planning

  1. Prepare an Annual Internal Audit Calendar (Annexure-1).
  2. Define audit scope, criteria, objectives, and schedule.
  3. Assign lead auditor and audit team ensuring independence from auditee departments.

5.2 Audit Execution

  1. Conduct opening meeting to brief the audit plan to department heads.
  2. Perform physical inspection, document review, and personnel interviews.
  3. Record all observations in Audit Observation Sheet (Annexure-2).
  4. Classify findings as critical, major, or minor based on potential risk to product quality.

5.3 Audit Reporting

  1. Prepare an Audit Summary Report (Annexure-3) within 5 working days of audit completion.
  2. Send report to relevant stakeholders for review and CAPA initiation.

5.4 Corrective and Preventive Actions (CAPA)

  1. Departments submit CAPA plans within 10 working days using CAPA Form (Annexure-4).
  2. QA verifies adequacy and implementation of CAPA during follow-up audits.

5.5 Audit Closure

  1. Once all CAPAs are verified and closed, update the Audit Closure Status Log (Annexure-5).
  2. Conduct a closing meeting and document audit closure in the audit report.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • GMP: Good Manufacturing Practices
  • CAPA: Corrective and Preventive Action
  • QA: Quality Assurance
  • QC: Quality Control

7. Documents

  1. Annual Audit Calendar – Annexure-1
  2. Audit Observation Sheet – Annexure-2
  3. Audit Summary Report – Annexure-3
  4. CAPA Form – Annexure-4
  5. Audit Closure Status Log – Annexure-5

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • 21 CFR Part 211 – GMP Requirements
  • WHO TRS 986 Annex 2 – GMP for Sterile Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Annual Audit Calendar

Department Scheduled Audit Date Lead Auditor
Production 10/01/2025 Sunita Reddy
Warehouse 15/03/2025 Rajesh Kumar

Annexure-2: Audit Observation Sheet

Observation No. Description Category Auditor
OBS-01 Incomplete BMR entries Major Sunita Reddy

Annexure-3: Audit Summary Report

Audit Date 12/06/2025
Audited Department Filling
No. of Observations 3
Report Prepared By Rajesh Kumar

Annexure-4: CAPA Form

Observation No. Corrective Action Preventive Action Responsible
OBS-01 Train operators on documentation Introduce BMR checklist Anita Mehta

Annexure-5: Audit Closure Status Log

Audit ID Closure Date Verified By Status
AUD-2025-01 25/06/2025 QA Officer Closed

Revision History

Revision Date Revision No. Details Reason Approved By
01/02/2022 1.0 Initial version New SOP implementation QA Head
18/06/2025 2.0 Updated CAPA workflow and annexures Annual review QA Head
Exit mobile version